Skip to main navigation Home PAD Facts QuantaFlo® Investor Info Contact Us Investors Home → Investor Info Investor Info Semler Scientific, Inc. is a company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers. Semler Scientific's mission is to develop, manufacture and market innovative products that assist its customers in evaluating and treating chronic diseases. Semler Scientific commercially launched its first patented and FDA- cleared product in 2011, and received FDA 510(k) clearance for QuantaFlo®, the next generation version of this product, in 2015. QuantaFlo® is a rapid point-of-care test that measures arterial blood flow in the extremities to aid in the diagnosis of peripheral arterial disease. QuantaFlo® is used by Semler Scientific's customers to more comprehensively evaluate their patients for risk of heart attacks and strokes. Semler Scientific believes it is positioned to provide valuable information to its insurance company and physician customers, which in turn permits them to better guide patient care. Intra 3 mo. 6 mo. 1 yr. Press Releases Nov 01, 2021 Semler Reports Third Quarter and Year-to-Date 2021 Financial Results Oct 22, 2021 Semler to Report Third Quarter and First Nine Months of 2021 Financial Results and Host Conference Call on November 1, 2021 View all press releases » Events Nov 1, 2021 at 4:30 PM EDT Semler Scientific 3Q 2021 Financial Results Sep 14 - Sep 15, 2021 2021 Best Ideas Growth (BIG5) Conference hosted by Lake Street Securities Presentations Semler November 2021 Presentation View all events & presentations » Investor Relations Investor Info Press Releases Events & Presentations Corporate Governance Financials & Filings Stock Information Analyst Coverage Contact Us Shareholder Tools Email Alerts Print Share Contact us Semler Scientific, Inc. 2344 Walsh Avenue Santa Clara, CA 95051 Call us toll-free at 877-774-4211 References Terms of Use Privacy Policy Copyright 2021 Semler Scientific, Inc. Back to Top